Glenn Short
Chief Scientific Officer at atai Life Sciences
About
Glenn Short is Chief Scientific Officer at atai Life Sciences, a role he took in 2025 after serving as Senior Vice President of Early Development from 2022. He leads internal innovation and early-stage product development, integrating translational medicine into development and clinical strategies, and has over 20 years of industry and research experience across venture-backed and public companies. He holds a Ph.D. in Chemistry from the University of Virginia and completed postdoctoral training in molecular biology at Massachusetts General Hospital/Harvard Medical School.
Colleagues at atai Life Sciences
Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Kevin Craig
Chief Medical Officer at atai Life Sciences
Laurent Fischer
Director at atai Life Sciences